Selected-GenAtlas references SOURCE GeneCards NCBI Gene Swiss-Prot Orphanet Ensembl
HGNC UniGene Nucleotide OMIM UCSC
Home Page
FLASH GENE
Symbol PCK1 contributors: mct - updated : 15-05-2020
HGNC name phosphoenolpyruvate carboxykinase 1 (soluble)
HGNC id 8724
PROTEIN
PHYSICAL PROPERTIES
STRUCTURE
motifs/domains
HOMOLOGY
interspecies homolog to murine Pck1
homolog to C.elegans r11a5.4
Homologene
FAMILY phosphoenolpyruvate carboxykinase family
CATEGORY enzyme
SUBCELLULAR LOCALIZATION     intracellular
intracellular,cytoplasm,organelle,mitochondria
intracellular,cytoplasm,cytosolic
basic FUNCTION
  • main control point for the regulation of gluconeogenesis
  • catalyzing the formation of phosphoenolpyruvate from oxaloacetate, with the release of carbon dioxide and GDP
  • functions in the pathway for the conversion of gluconeogenic precursors to glucose and contributes to glycerol-3-phosphate synthesis through glyceroneogenesis
  • PCK1 plays an important role in both the mammary gland adipocytes and epithelial cells during lactation
  • acid-induced PCK1 provides glucose for acid-base homeostasis at an individual level, which is supported by rapid pumping of H(+) via V-ATPase at the cellular level
  • PCK1 plays a regulatory role in gluconeogenesis and glyceroneogenesis
  • PCK1 activity contributes to metabolic reprogramming and polarization in macrophages
  • importance of the protein kinase activity of PCK1 in the activation of SREBPs, lipogenesis and the development of hepatocellular carcinoma (HCC)
  • CELLULAR PROCESS
    PHYSIOLOGICAL PROCESS
    PATHWAY
    metabolism carbohydrate , energetic
    signaling
    a component
    INTERACTION
    DNA
    RNA
    small molecule nucleotide,
    GTP
    protein
  • PCK1 is acetylated by the EP300 acetyltransferase, and this acetylation stimulates the interaction between PCK1 and UBR5, a HECT domain containing E3 ubiquitin ligase, therefore promoting PCK1 ubiquitinylation and degradation
  • overexpression of ESRRG induced PCK1 and G6PC gene expression and glucose production in primary hepatocytes
  • thyroid hormone (TH), a regulator of hepatic gluconeogenesis acts through its nuclear receptor (THRA, THRB) to induce the expression of PCK1 and G6PC
  • mechanistically, LAMTOR5 inhibited the expression of PCK1 through down-regulating transcription factor FOXO1 in hepatoma cells
  • CREB3L3 regulates the rhythmic expression of the genes encoding the rate-limiting enzymes for glycogenolysis and gluconeogenesis, including PYGL, PCK1, and G6PC
  • PCK1 reduces the stability of LDHA through posttranslational regulation and the effects of PCK1 on glucose metabolism, cell proliferation and metastasis are mediated via the inhibition of LDHA
  • gluconeogenic enzyme PCK1 phosphorylates INSIG1/INSIG2 for lipogenesis
  • cell & other
    REGULATION
    induced by thyroid hormone T3 and CAMP
    glucagon
    repressed by insulin
    Other acetylation regulates the stability of the gluconeogenic rate-limiting enzyme PCK1, thereby modulating cellular response to glucose
    ASSOCIATED DISORDERS
    corresponding disease(s) PCKDC
    Other morbid association(s)
    TypeGene ModificationChromosome rearrangementProtein expressionProtein Function
    tumoral     --low  
    lower in clinical hepatocellular carcinoma (HCC) tissues than that in normal tissues
    Susceptibility
  • to type 2 diabetes mellitus
  • to late-onset Alzheimer's disease
  • Variant & Polymorphism SNP promoter SNP associated with type 2 diabetes mellitus
    Candidate gene
    Marker
  • PCK1 may serve as a candidate prognostic biomarker in clear cell renal cell carcinoma (ccRCC)
  • Therapy target
    SystemTypeDisorderPubmed
    cancerurinary 
    targeting the PCK1/LDHA pathway might be a new strategy to selectively inhibit tumor metabolism in in clear cell renal cell carcinoma
    cancerdigestivecolon
    DHODH and PCK1 are metabolic therapeutic targets in Colorectal metastatic progression
    ANIMAL & CELL MODELS